[Severe pseudotumoral panniculitis in the child: cytophagic histiocytic panniculitis? Favorable outcome with chemotherapy].
Labeille
B
B
Service de Dermatologie et Vénéréologie, Centre Hospitalier Régional et Universitaire, Hôpital Sud, Amiens.
Pautard
B
B
Pare
F
F
Lok
C
C
Gontier
M F
MF
Devauchelle
B
B
Delobel
J
J
Denoeux
J P
JP
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D002648:Child; D003520:Cyclophosphamide / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000008:administration & dosage; D015614:Histiocytosis / Q000473:pathology*; D006801:Humans; D007019:Hypoproteinemia / Q000150:complications; D007970:Leukopenia / Q000150:complications; D008297:Male; D015434:Panniculitis / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D011241:Prednisone / Q000008:administration & dosage; D012878:Skin Neoplasms / Q000473:pathology; D013163:Splenomegaly; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone
Panniculite sévère pseudotumorale de l'enfant: panniculite histiocytaire cytophagique? Evolution favorable sous chimiothérapie.